Does Mineralys Therapeutics, Inc. (MLYS) Have the Potential to Rally 154.21% as Wall Street Analysts Expect?

Mineralys Therapeutics, Inc. (MLYS) closed the last trading session at $14.26, gaining 1.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $36.25 indicates a 154.2% upside potential.The mean estimate comprises eight short-term price targets with a standard deviation of $11.25. While the lowest estimate of $15.00 indicates a 5.2% increase from the current price level, the most opti ...